Antonia Victoria Seligowski, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stress Disorders, Post-Traumatic | 29 | 2024 | 4629 | 3.970 |
Why?
|
Conditioning, Classical | 5 | 2020 | 368 | 1.500 |
Why?
|
Autonomic Nervous System | 4 | 2024 | 707 | 1.230 |
Why?
|
Cardiovascular Diseases | 8 | 2024 | 15645 | 1.010 |
Why?
|
Fear | 6 | 2023 | 1496 | 0.980 |
Why?
|
Heart Rate | 5 | 2024 | 4209 | 0.920 |
Why?
|
Progesterone | 2 | 2024 | 752 | 0.860 |
Why?
|
Models, Psychological | 3 | 2015 | 823 | 0.830 |
Why?
|
Extinction, Psychological | 3 | 2021 | 367 | 0.710 |
Why?
|
Estradiol | 2 | 2024 | 1951 | 0.700 |
Why?
|
Blinking | 1 | 2020 | 135 | 0.680 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 787 | 0.620 |
Why?
|
Vagus Nerve | 1 | 2020 | 458 | 0.580 |
Why?
|
Dissociative Disorders | 2 | 2019 | 234 | 0.580 |
Why?
|
Bullying | 1 | 2019 | 235 | 0.530 |
Why?
|
Cardiovascular System | 1 | 2024 | 839 | 0.530 |
Why?
|
Sex Offenses | 1 | 2019 | 355 | 0.490 |
Why?
|
Crime Victims | 1 | 2019 | 348 | 0.490 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1321 | 0.470 |
Why?
|
Evoked Potentials | 1 | 2020 | 1050 | 0.460 |
Why?
|
Combat Disorders | 2 | 2012 | 300 | 0.430 |
Why?
|
Emotions | 2 | 2015 | 2760 | 0.420 |
Why?
|
Behavioral Symptoms | 1 | 2014 | 188 | 0.410 |
Why?
|
Veterans | 6 | 2022 | 2666 | 0.410 |
Why?
|
Learning | 1 | 2018 | 1754 | 0.310 |
Why?
|
Blood Pressure | 1 | 2024 | 8531 | 0.300 |
Why?
|
Personal Satisfaction | 1 | 2012 | 643 | 0.290 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4813 | 0.230 |
Why?
|
Stress, Psychological | 4 | 2024 | 4526 | 0.230 |
Why?
|
Factor Analysis, Statistical | 3 | 2016 | 1002 | 0.230 |
Why?
|
Adult | 16 | 2024 | 223317 | 0.210 |
Why?
|
Female | 25 | 2024 | 396660 | 0.210 |
Why?
|
Humans | 39 | 2024 | 767040 | 0.210 |
Why?
|
Hypertension | 1 | 2022 | 8615 | 0.200 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3851 | 0.200 |
Why?
|
Quality of Life | 3 | 2016 | 13485 | 0.180 |
Why?
|
Retirement | 2 | 2012 | 198 | 0.180 |
Why?
|
Amygdala | 4 | 2024 | 1375 | 0.180 |
Why?
|
Male | 22 | 2024 | 364203 | 0.180 |
Why?
|
Stroke | 1 | 2023 | 9746 | 0.180 |
Why?
|
Gonadal Steroid Hormones | 1 | 2024 | 707 | 0.170 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2022 | 270 | 0.160 |
Why?
|
Endocrine System | 1 | 2019 | 113 | 0.160 |
Why?
|
Hypothalamus | 1 | 2024 | 1002 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36582 | 0.160 |
Why?
|
Stress Disorders, Traumatic | 1 | 2019 | 50 | 0.150 |
Why?
|
Law Enforcement | 1 | 2019 | 112 | 0.150 |
Why?
|
Carotid Artery Diseases | 1 | 2024 | 872 | 0.150 |
Why?
|
Neurophysiology | 1 | 2018 | 144 | 0.140 |
Why?
|
Implosive Therapy | 1 | 2019 | 127 | 0.140 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2016 | 6023 | 0.140 |
Why?
|
Middle Aged | 13 | 2024 | 223233 | 0.140 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2021 | 1065 | 0.140 |
Why?
|
Students | 2 | 2018 | 1744 | 0.130 |
Why?
|
Sleep | 1 | 2012 | 4816 | 0.130 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2019 | 793 | 0.130 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 736 | 0.130 |
Why?
|
Young Adult | 6 | 2024 | 59980 | 0.130 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 301 | 0.120 |
Why?
|
Comorbidity | 3 | 2023 | 10582 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1515 | 0.110 |
Why?
|
Arousal | 1 | 2019 | 1174 | 0.110 |
Why?
|
Depression | 4 | 2023 | 8234 | 0.110 |
Why?
|
Inflammation | 2 | 2024 | 10869 | 0.110 |
Why?
|
Physical Examination | 1 | 2019 | 1265 | 0.110 |
Why?
|
Aging | 1 | 2012 | 8729 | 0.110 |
Why?
|
Electromyography | 1 | 2018 | 1398 | 0.100 |
Why?
|
Sex Factors | 2 | 2024 | 10622 | 0.100 |
Why?
|
Electric Stimulation Therapy | 1 | 2019 | 635 | 0.100 |
Why?
|
Writing | 1 | 2014 | 200 | 0.100 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2022 | 1498 | 0.100 |
Why?
|
Narration | 1 | 2014 | 223 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 4 | 2022 | 18063 | 0.100 |
Why?
|
Committee Membership | 1 | 2012 | 18 | 0.100 |
Why?
|
Ethics Committees | 1 | 2012 | 51 | 0.100 |
Why?
|
Vietnam Conflict | 1 | 2012 | 100 | 0.100 |
Why?
|
Health Status | 2 | 2016 | 4091 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6550 | 0.090 |
Why?
|
Child Abuse | 1 | 2020 | 1090 | 0.090 |
Why?
|
Pilot Projects | 1 | 2024 | 8732 | 0.090 |
Why?
|
Heart | 1 | 2024 | 4429 | 0.090 |
Why?
|
Self Report | 3 | 2020 | 3773 | 0.090 |
Why?
|
Genome-Wide Association Study | 4 | 2022 | 12790 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2629 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1900 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2647 | 0.080 |
Why?
|
Universities | 1 | 2014 | 1004 | 0.080 |
Why?
|
Social Stigma | 1 | 2016 | 788 | 0.080 |
Why?
|
United States | 6 | 2019 | 72971 | 0.080 |
Why?
|
Violence | 1 | 2014 | 931 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12250 | 0.070 |
Why?
|
Cerebral Cortex | 1 | 2024 | 5754 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2745 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10393 | 0.070 |
Why?
|
Life Change Events | 1 | 2012 | 956 | 0.070 |
Why?
|
Regression Analysis | 2 | 2014 | 6331 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 16036 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2016 | 2662 | 0.060 |
Why?
|
Brain | 2 | 2022 | 27163 | 0.050 |
Why?
|
Prefrontal Cortex | 2 | 2024 | 2224 | 0.050 |
Why?
|
Adolescent | 3 | 2020 | 89046 | 0.050 |
Why?
|
Electroencephalography | 1 | 2018 | 6282 | 0.050 |
Why?
|
Aged | 5 | 2024 | 171319 | 0.050 |
Why?
|
Social Support | 1 | 2012 | 2192 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3232 | 0.050 |
Why?
|
Risk Factors | 3 | 2024 | 74886 | 0.050 |
Why?
|
Cohort Studies | 1 | 2024 | 41718 | 0.050 |
Why?
|
Anxiety | 2 | 2016 | 4670 | 0.050 |
Why?
|
Losartan | 1 | 2021 | 262 | 0.040 |
Why?
|
Illinois | 1 | 2019 | 120 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2012 | 59548 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2023 | 14766 | 0.040 |
Why?
|
Gyrus Cinguli | 1 | 2023 | 1118 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2028 | 0.030 |
Why?
|
Psycholinguistics | 1 | 2014 | 79 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2702 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2353 | 0.030 |
Why?
|
Neural Pathways | 1 | 2024 | 3078 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1626 | 0.030 |
Why?
|
Psychological Tests | 1 | 2014 | 642 | 0.020 |
Why?
|
Role | 1 | 2012 | 176 | 0.020 |
Why?
|
Veterans Health | 1 | 2012 | 216 | 0.020 |
Why?
|
Self-Assessment | 1 | 2012 | 400 | 0.020 |
Why?
|
Social Adjustment | 1 | 2012 | 634 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 13085 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2979 | 0.020 |
Why?
|
Hippocampus | 1 | 2021 | 3777 | 0.020 |
Why?
|
Exercise | 1 | 2024 | 5954 | 0.020 |
Why?
|
Firearms | 1 | 2014 | 630 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12451 | 0.020 |
Why?
|
Psychometrics | 1 | 2016 | 3060 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22254 | 0.020 |
Why?
|
Age of Onset | 1 | 2012 | 3344 | 0.020 |
Why?
|
Alcoholism | 1 | 2016 | 1980 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15925 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5924 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16718 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2783 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20741 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7848 | 0.010 |
Why?
|
Mental Health | 1 | 2012 | 3272 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54886 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65295 | 0.010 |
Why?
|
Child | 1 | 2020 | 80771 | 0.010 |
Why?
|